Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

BUY
$13.89 - $15.04 $11,445 - $12,392
824 Added 5.39%
16,099 $224,000
Q4 2023

Jan 12, 2024

SELL
$13.36 - $15.43 $10,260 - $11,850
-768 Reduced 4.79%
15,275 $218,000
Q3 2023

Oct 13, 2023

BUY
$15.03 - $16.32 $101,828 - $110,568
6,775 Added 73.1%
16,043 $248,000
Q1 2023

Apr 28, 2023

BUY
$15.28 - $16.48 $141,615 - $152,736
9,268 New
9,268 $153,000
Q2 2022

Jul 29, 2022

SELL
$13.12 - $15.03 $127,644 - $146,226
-9,729 Closed
0 $0
Q1 2022

Apr 29, 2022

SELL
$13.54 - $15.35 $199,051 - $225,660
-14,701 Reduced 60.18%
9,729 $139,000
Q3 2021

Nov 01, 2021

SELL
$16.3 - $17.26 $635 - $673
-39 Reduced 0.16%
24,430 $400,000
Q2 2021

Aug 12, 2021

SELL
$16.55 - $18.64 $147,526 - $166,156
-8,914 Reduced 26.7%
24,469 $412,000
Q1 2021

May 13, 2021

BUY
$16.71 - $19.9 $148,969 - $177,408
8,915 Added 36.44%
33,383 $610,000
Q3 2020

Nov 09, 2020

SELL
$17.1 - $19.19 $68 - $76
-4 Reduced 0.02%
24,468 $437,000
Q2 2020

Jul 20, 2020

BUY
$14.59 - $19.5 $2,918 - $3,900
200 Added 0.82%
24,472 $439,000
Q1 2020

Apr 30, 2020

SELL
$13.02 - $20.31 $325 - $507
-25 Reduced 0.1%
24,272 $368,000
Q4 2019

Jan 28, 2020

BUY
$16.88 - $20.83 $67 - $83
4 Added 0.02%
24,297 $479,000
Q3 2019

Nov 04, 2019

BUY
$16.15 - $17.99 $2,357 - $2,626
146 Added 0.6%
24,293 $418,000
Q2 2019

Jul 29, 2019

BUY
$16.58 - $20.49 $29,595 - $36,574
1,785 Added 7.98%
24,147 $427,000
Q1 2019

Apr 29, 2019

BUY
$16.7 - $21.52 $373,445 - $481,230
22,362 New
22,362 $456,000

Others Institutions Holding TAK

About TAKEDA PHARMACEUTICAL CO LTD


  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $43.1B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.